Bláha Vladimír, Bláha Milan, Lánská Miriam, Havel Eduard, Vyroubal Pavel, Zadák Zdeněk, Žák Pavel, Sobotka Luboš
Vnitr Lek. 2014 Nov;60(11):970-6.
LDL-apheresis is an extracorporeal elimination technique, which specifically removes LDL-cholesterol from the circulation. There are six methods for the selective LDL-cholesterol removal these days. The main indications for LDL-apheresis are the diagnosis of homozygous familial hypercholesterolemia, heterozygous familial hypercholesterolemia which is refractory the standard care and intolerance of routine care, and also patients with lipoprotein(a) increase resistant to the farmacotherapy. There is still debate which LDL-cholesterolemia is indication for LDL-apheresis therapy, and the recommendation differs among various countries. Despite large randomized trials are missing, there are several good quality studies to conclude, that the beneficial cardiovascular effects of LDL-apheresis in severe hypercholesterolemia are important and beneficial.
低密度脂蛋白单采术是一种体外清除技术,它能特异性地从循环中去除低密度脂蛋白胆固醇。目前有六种选择性去除低密度脂蛋白胆固醇的方法。低密度脂蛋白单采术的主要适应证包括纯合子家族性高胆固醇血症的诊断、对标准治疗难治且不耐受常规治疗的杂合子家族性高胆固醇血症,以及对药物治疗耐药的脂蛋白(a)升高患者。关于哪种低密度脂蛋白胆固醇血症是低密度脂蛋白单采术治疗的适应证仍存在争议,不同国家的推荐也有所不同。尽管缺乏大型随机试验,但有几项高质量研究得出结论,即低密度脂蛋白单采术对严重高胆固醇血症有益的心血管效应是重要且有益的。